Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.
All content for GT: The Podcast is the property of Glaucoma Today and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.
On this episode of Survey Says, a special edition of GT: The Podcast, I. Paul Singh, MD, is joined by guests Lorraine M. Provencher, MD, and Brian Shafer, MD, to review a real case from his practice. They discuss details of the case, including patient risk factors and possible treatment goals, and consider their choices for managing the case in the most effective manner while still leaving options on the table for future treatment. Later, the panelists find out how their colleagues would manage the case, based on results of a social media poll of GT’s audience.
GT: The Podcast
Keeping pace with the rapidly evolving glaucoma space, GT: The Podcast brings the latest thought-provoking information and insights on glaucoma to the ophthalmic community. Leading experts discuss the many developments advancing the understanding and treatment of the disease, with the collective goal of ushering in a new era of glaucoma care. GT: The Podcast is produced by Bryn Mawr Communications and Glaucoma Today.